
The current JNJ market cap is 401.25B. The company's latest EPS is USD 5.8423 and P/E is 28.53.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 21.4B | 21.38B | 22.45B | 22.47B | 22.52B |
Operating Income | 4.19B | 5.91B | 6.28B | 5.04B | 3.58B |
Net Income | 4.05B | 3.26B | 4.69B | 2.69B | 3.43B |
Year End December 28 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 82.58B | 93.78B | 94.94B | 85.16B | 88.82B |
Operating Income | 19.49B | 23.4B | 23.38B | 21.21B | 20.8B |
Net Income | 14.71B | 20.88B | 17.94B | 35.15B | 14.07B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 167.56B | 171.97B | 181.09B | 178.29B | 180.1B |
Total Liabilities | 98.78B | 101.95B | 109.55B | 108.13B | 108.61B |
Total Equity | 68.77B | 70.02B | 71.54B | 70.16B | 71.49B |
Year End December 28 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 174.89B | 182.02B | 187.38B | 167.56B | 180.1B |
Total Liabilities | 111.62B | 108B | 110.57B | 98.78B | 108.61B |
Total Equity | 63.28B | 74.02B | 76.8B | 68.77B | 71.49B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 22.79B | 3.66B | 9.29B | 17.28B | 24.27B |
Investing | 878M | -464M | -14.15B | -17.28B | -18.6B |
Financing | -15.83B | 546M | 8.09B | -1.79B | -3.13B |
Year End December 28 2024 | 2021 | 2022 | 2023 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 23.54B | 23.41B | 21.19B | 22.79B | 24.27B |
Investing | -20.83B | -8.68B | -12.37B | 878M | -18.6B |
Financing | -6.12B | -14.05B | -8.87B | -15.83B | -3.13B |
Market Cap | 401.25B |
Price to Earnings Ratio | 28.53 |
Price to Sales Ratio | 4.52 |
Price to Cash Ratio | 16.65 |
Price to Book Ratio | 5.61 |
Dividend Yield | 2.98% |
Shares Outstanding | 2.41B |
Average Volume (1 week) | 10.02M |
Average Volume (1 Month) | 9.25M |
52 Week Change | 4.50% |
52 Week High | 169.99 |
52 Week Low | 140.68 |
Spread (Intraday) | 2.01 (1.21%) |
Company Name | Johnson and Johnson |
Address |
one johnson & johnson plaza new brunswick, new jersey 08933 |
Website | https://www.jnj.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.